DMPK CONSULTING SUPPORT SERVICES
DMPK CONSULTING SUPPORT SERVICES
批准号:
10619428
负责人:
PAUL PEARSON
金额:
$4.84万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-30 至 2024-09-29
关键词:
AddressChemistryClinical ResearchConsultConsultationsContractorDataData AnalysesDevelopmentDrug KineticsExperimental DesignsFormulationIndividualLeadProtocols documentationResearch DesignRoleServicesStrategic PlanningUnited States National Institutes of Healthassay developmentdesigndrug developmentdrug discoverydrug metabolismlead optimizationprograms
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Drug Metabolism and Pharmacokinetics (DMPK) consultants may be required to
evaluate PK study protocols and data, assist with study design, and advise NIH staff on
the establishment of milestones related to DMPK. Specific consulting responsibilities
will depend on the expertise of the individual consultant and the needs of individual
projects. DMPK-related consultation services may be required on an ad hoc basis or on
LDTs.
The role of the Drug Metabolism and Pharmacokinetics consultant may include but is not
limited to the following responsibilities and tasks:
• In partnership with other consultants, contractors, and the NIH staff, advise,
strategically plan, and manage pharmacokinetic (PK) programs to facilitate assay
development, exploratory chemistry, lead optimization, formulation activities,
IND enabling, and clinical studies.
• Serve as the PK expert in order to identify potential drug discovery and
development challenges such as lead identification and lead development and
suggest strategies to address these challenges.
• Collaborate on design of investigative PK studies, PK/PD strategy, experimental
design, data analysis and interpretation for discovery and translational projects in
support of NIH drug discovery and development projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].
-
批准号:10721124
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2022
-
负责人:PAUL PEARSON
-
依托单位:--
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].
-
批准号:10788018
-
项目类别:
-
资助金额:$7.7万
-
财政年份:2022
-
负责人:PAUL PEARSON
-
依托单位:--
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].
-
批准号:10788017
-
项目类别:
-
资助金额:$2.2万
-
财政年份:2022
-
负责人:PAUL PEARSON
-
依托单位:--
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].
-
批准号:10721125
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2022
-
负责人:PAUL PEARSON
-
依托单位:--
DMPK CONSULTING SUPPORT SERVICES
-
批准号:10495521
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2021
-
负责人:PAUL PEARSON
-
依托单位:--
NIH DRUG DEVELOPMENT CONSULTING SERVICES
-
批准号:8356074
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2011
-
负责人:PAUL PEARSON
-
依托单位:
NIH DRUG DEVELOPMENT CONSULTING SERVICES
-
批准号:8429009
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2011
-
负责人:PAUL PEARSON
-
依托单位:
TAS::75 0849::TAS TOPIC 255 SELECTIVE AND POTENT INHIBITORS OF TUMOR SPECIFIC GL
-
批准号:8351294
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2011
-
负责人:PAUL PEARSON
-
依托单位:
NIH DRUG DEVELOPMENT CONSULTING SERVICES
-
批准号:9035331
-
项目类别:
-
资助金额:$3.6万
-
财政年份:2011
-
负责人:PAUL PEARSON
-
依托单位:--
NIH DRUG DEVELOPMENT CONSULTING SERVICES
-
批准号:8844712
-
项目类别:
-
资助金额:$3.6万
-
财政年份:2011
-
负责人:PAUL PEARSON
-
依托单位:--
NIH DRUG DEVELOPMENT CONSULTING SERVICES
-
批准号:8602417
-
项目类别:
-
资助金额:$11.2万
-
财政年份:2011
-
负责人:PAUL PEARSON
-
依托单位:
国内基金
海外基金
SCIENCE CHINA Chemistry
-
批准号:21224001
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:朱晓文
-
依托单位:
Science China Chemistry
-
批准号:21024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:朱晓文
-
依托单位:
运用Linkage Chemistry合成新型聚合物缀合物和刷形共聚物
-
批准号:20974058
-
项目类别:面上项目
-
资助金额:12.0万元
-
批准年份:2009
-
负责人:袁金颖
-
依托单位: